Cuellar-Guzmán LF, Ferretiz-López G

Language: Spanish
References: 16
Page: 187-190
PDF size: 133.05 Kb.

ABSTRACT

Cancer is the leading cause of death worldwide, in Mexico it is the third cause of death with 12% of all deaths, reaching 222 deaths per day. According to data from the 2017 Forum of Leaders against Cancer, it is estimated that by 2025 the incidence in Mexico will increase by 50%, going from 147,000 to 220,000 new cases per year. Data from 52 reviewed articles showed that oncological pain reached figures of 33% in cured patients, 59% in patients with oncological treatment and 64% in patients with metastasis. More than a third of patients with pain in this review classified their pain as moderate to severe. The optimal management of acute or chronic pain in the oncological patient requires a comprehensive approach based on evidence, taking into account the previous treatment with opioids, addressing breakthrough pain charts and making a constant self-assessment of strategy and results.

REFERENCES

1. Van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437-1449.

2. International Association for the Study of Pain. 2008-2009 Cancer Pain. Vol. 2015. Disponible en: http://www.iasp-pain.org/GlobalYear/CancerPain

3. Paice J. Glob. libr. Women’s med., (ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.10269

4. Grosu I, de Kock M. New concepts in acute pain management: strategies to prevent chronic postsurgical pain, opioid-induced hyperalgesia, and outcome measures. Anesthesiol Clin. 2011;29:311-327.

5. Khan R, Kamran A, Blakeway E, et al. Catastrophizing: a predictive factor for postoperative pain. Am J Surg. 2011;201:122-131.

6. Lewis NL, Williams JE. Acute pain management in patients receiving opioids for chronic and cancer pain, Continuing Education in Anaesthesia. Critical Care & Pain. 2005;5.

7. Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids. Focus on transdermal fentanyl. Clin Pharmacokinet. 2000;38:59-89.

8. Fabregat-Cid G, Asensio-Samper JM, Villanueva-Pérez V, López-Alarcón MD, De Andrés-Ibáñez J. Manejo perioperatorio del dolor en el paciente en tratamiento crónico con opiáceos. Consorcio Hospital General Universitario de Valencia. Rev Esp Anestesiol Reanim. 2011;58:25-33.

9. Carroll IR, Angst MS, Clark JD. Management of perioperative pain patients chronically consuming opioids. Reg Anesth Pain Med. 2004;29:576-591.

10. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012;116:248-273.

11. Kodali BS, Oberoi J. Management of postoperative pain [Systematic reviews and meta-analyses. In: Rosenquist EW, Doucette K, editors. UpToDate. Waltham (MA): UpToDate; 2014.

12. Melemeni A, Staikou C, Fassoulaki A. Review article: gabapentin for acute and chronic post-surgical pain. Signa Vitae. 2007;2:S42-S51.

13. van den Beuken-van Everdingen MH, de Graeff A, Jongen JL, Dijkstra D, Mostovaya I, Vissers KC. Pharmacological treatment of pain in cancer patients: the role of adjuvant analgesics, a systematic review. Pain Pract. 2017;17:409-419.

14. Momeni M, Crucitti M, De Kock M. Patient-controlled analgesia in the management of postoperative pain. Drugs. 2006;66:2321-2337.

15. Lovich-Sapola J, Simth CE, Brandt CP. Postoperative pain control. Surg Clin N Am. 2015;95:301-318.

16. Grosu I, de Kock M. New concepts in acute pain management: strategies to prevent chronic postsurgical pain, opioid-induced hyperalgesia, and outcome measures. Anesthesiol Clin. 2011;29:311-327.